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The Predictive Low Glucose Management (PLGM) sys-
tem consists of a Medtronic Veo pump, Enlite sensor,
MiniLink REAL-Time transmitter, Bluetooth-RF transla-
tor and a predictive algorithm operating from a Black-
berry smartphone. The system suspended insulin
delivery when the pre-set hypoglycaemic threshold of
4.4 mmol/L was predicted to be reached in 30 minutes.
The aim of this study was to determine the plasma glu-
cose profile with the PLGM system when hypoglycaemia
was induced by (a) moderate-intensity exercise, (b) subcu-
taneous insulin bolus and (c) increasing the overnight
basal infusion rate in individuals with type 1 diabetes. The
primary outcome was the plasma glucose nadir following
each hypoglycaemic stimulus with and without PLGM.
Participants performed 30-60 minutes of moderate-
intensity exercise or were administered a subcutaneous
insulin bolus following a glucose stabilisation period on
basal continuous subcutaneous insulin infusion. In parti-
cipants studied with increased overnight basal rates,
hypoglycaemia was induced by increasing basal rates by
180%. They were randomised and studied on 2 separate
days; with PLGM off and with PLGM on. On both days,
participants were observed until plasma glucose dropped
to 2.8 mmol/L or were symptomatic.
Results
A) PLGM suspended basal insulin in 9/13 participants who
performed moderate-intensity exercise resulting in a higher
glucose nadir in 6/9 participants (66%).The mean±SD
glucose nadir with PLGM off and on was 3.38±0.44 mmol/L
and 3.5±0.65mmol/L respectively. (p=0.27)
B) PLGM suspended basal insulin in 27 participants
in whom SC insulin bolus was administered resulting
in a higher glucose nadir in 20 participants (74%). The
mean±SD glucose nadir with PLGM off and on was
3.33±0.47mmol/L and 3.71±0.5mmol/L respectively.
(p=0.003)
C) PLGM suspended basal insulin in 6/6 participants in
whom overnight basal rates were increased resulting in a
higher glucose nadir in 5/6 participants (83%). The mean±
SD glucose nadir with PLGM off and on was 2.7±
0.29mmol/L and 3.9±1.11mmol/L respectively. (p=0.05)
Sensor-augmented pump therapy with the PLGM sys-
tem is likely to be effective in reducing the risk of hypo-
glycaemia. The system appears to be more effective
when hypoglycaemia is induced by insulin bolus and
increased overnight basal rates than with exercise.
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